NYKODE THERAPEUTICS ASANYKODE THERAPEUTICS ASANYKODE THERAPEUTICS ASA

NYKODE THERAPEUTICS ASA

2.760NOKD
−0.064−2.27%
At close at Jan 10, 15:25 UTC
NOK
No trades
See on Supercharts

NYKD fundamentals

NYKODE THERAPEUTICS ASA earnings per share and revenue

NYKD earnings per share for the last quarter are -0.42 NOK whereas the estimation was -0.47 NOK which accounts for 10.41% surprise. Company revenue for the same period amounts to 6.99 M NOK despite the estimated figure of 30.90 M NOK. Estimated earnings per share for the next quarter are -0.54 NOK, and revenue is expected to reach 15.16 M NOK. Also watch annual changes over time to get a bigger picture of NYKD earnings per share and revenue dynamics.

Next report date
Feb 26, 2025
Report periodQ4 2024
EPS estimate−0.54NOK
Revenue estimate‪15.16 M‬NOK
EPS
Forecast
Q1 '20
Q2 '20
Q3 '20
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
‪−0.68‬
‪−0.51‬
‪−0.34‬
‪−0.17‬
‪0.00‬
Reported
Estimate
Currency: NOK
Q1 '20
Q2 '20
Q3 '20
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Reported
‪−0.58‬
‪−0.32‬
‪−0.37‬
‪−0.16‬
‪−0.51‬
‪−0.24‬
‪−0.42‬
Estimate
‪0.00‬
‪−0.42‬
‪−0.64‬
‪−0.53‬
‪−0.50‬
‪−0.53‬
‪−0.47‬
‪−0.54‬
‪−0.22‬
‪−0.22‬
‪−0.22‬
Surprise
+42.65%
+68.67%
−2.41%
+54.22%
+10.41%
Revenue
Forecast
Q1 '20
Q2 '20
Q3 '20
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
‪0.00‬
‪‪17.00 M‬‬
‪‪34.00 M‬‬
‪‪51.00 M‬‬
‪‪68.00 M‬‬
Reported
Estimate
Currency: NOK
Q1 '20
Q2 '20
Q3 '20
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Reported
‪‪7.06 M‬‬
‪‪54.80 M‬‬
‪‪30.08 M‬‬
‪‪22.32 M‬‬
‪‪10.79 M‬‬
‪‪5.92 M‬‬
‪‪6.99 M‬‬
Estimate
‪‪32.67 M‬‬
‪‪9.81 M‬‬
‪‪33.18 M‬‬
‪‪31.93 M‬‬
‪‪64.37 M‬‬
‪‪42.27 M‬‬
‪‪30.90 M‬‬
‪‪15.16 M‬‬
‪0.00‬
‪0.00‬
‪0.00‬
Surprise
−78.40%
−9.36%
−30.12%
−83.24%
−86.00%
−77.39%